Double-blind, Randomised, Placebo-controlled, Multi-centre Phase II Study to Evaluate the Efficacy and Safety of Three Different Dosages of Oral Trichuris Suis Ova (TSO) Suspension in Active Crohn's Disease

Trial Profile

Double-blind, Randomised, Placebo-controlled, Multi-centre Phase II Study to Evaluate the Efficacy and Safety of Three Different Dosages of Oral Trichuris Suis Ova (TSO) Suspension in Active Crohn's Disease

Discontinued
Phase of Trial: Phase II

Latest Information Update: 06 Sep 2016

At a glance

  • Drugs Trichuris suis ova (Primary)
  • Indications Crohn's disease
  • Focus Therapeutic Use
  • Acronyms TRUST-2; TRUST-II
  • Sponsors Dr Falk Pharma
  • Most Recent Events

    • 12 Nov 2013 Status changed from recruiting to discontinued, according to a Coronado Biosciences media release.
    • 12 Sep 2013 Data from a second interim analysis and trial completion are expected during the fourth quarter of 2013, according to a Coronado Biosciences media release.
    • 08 May 2013 Data from a second interim analysis are expected to be reported during the second half of 2013, according to a Coronado Biosciences media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top